Evidence for altered synthesis of type II collagen in patients with osteoarthritis
- PMID: 9854047
- PMCID: PMC509166
- DOI: 10.1172/JCI4853
Evidence for altered synthesis of type II collagen in patients with osteoarthritis
Abstract
There is evidence to suggest that the synthesis of type II collagen is increased in osteoarthritis (OA). Using an immunoassay, we show that the content of the C-propeptide of type II procollagen (CPII), released extracellularly from the newly synthesized molecule, is directly related to the synthesis of this molecule in healthy and osteoarthritic articular cartilages. In OA cartilage, CPII content is often markedly elevated (mean 7.6-fold), particularly in the mid and deep zones, reaching 29.6% of the content in newborn. Synthesis is also directly related to total collagen II content in OA, suggesting its importance in maintaining collagen content and cartilage structure. The release of CPII from cartilage is correlated directly with cartilage content. However, the increase in CPII in OA cartilage is not reflected in serum, where a significant reduction is observed. Together these studies provide evidence for alterations in procollagen II synthesis in vivo in patients with OA.
Similar articles
-
The pathobiology of focal lesion development in aging human articular cartilage and molecular matrix changes characteristic of osteoarthritis.Arthritis Rheum. 2003 May;48(5):1261-70. doi: 10.1002/art.10976. Arthritis Rheum. 2003. PMID: 12746899
-
Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis.Arthritis Rheum. 2002 Oct;46(10):2613-24. doi: 10.1002/art.10576. Arthritis Rheum. 2002. PMID: 12384919
-
Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1).Arthritis Rheum. 2000 Mar;43(3):673-82. doi: 10.1002/1529-0131(200003)43:3<673::AID-ANR25>3.0.CO;2-8. Arthritis Rheum. 2000. PMID: 10728762
-
The role of type IX collagen in osteoarthritis and rheumatoid arthritis.Orthop Rev. 1993 Feb;22(2):165-70. Orthop Rev. 1993. PMID: 8451069 Review.
-
[Regulation of collagen from the cartilage by interleukin-1].Rev Prat. 1996 Dec 1;46(19 Spec No):S32-6. Rev Prat. 1996. PMID: 8978155 Review. French. No abstract available.
Cited by
-
Xylosyltransferase-I regulates glycosaminoglycan synthesis during the pathogenic process of human osteoarthritis.PLoS One. 2012;7(3):e34020. doi: 10.1371/journal.pone.0034020. Epub 2012 Mar 30. PLoS One. 2012. PMID: 22479506 Free PMC article.
-
Selective COX-2 inhibitor ameliorates osteoarthritis by repressing apoptosis of chondrocyte.Med Sci Monit. 2012 Jun;18(6):BR247-52. doi: 10.12659/msm.882901. Med Sci Monit. 2012. PMID: 22648246 Free PMC article.
-
Biomarkers in spondyloarthritis.Curr Rheumatol Rep. 2006 Aug;8(4):283-6. doi: 10.1007/s11926-006-0009-3. Curr Rheumatol Rep. 2006. PMID: 16839507 Review.
-
Transforming growth factor-beta2 suppresses collagen cleavage in cultured human osteoarthritic cartilage, reduces expression of genes associated with chondrocyte hypertrophy and degradation, and increases prostaglandin E(2) production.Am J Pathol. 2006 Jan;168(1):131-40. doi: 10.2353/ajpath.2006.050369. Am J Pathol. 2006. PMID: 16400016 Free PMC article.
-
Quantitative proteomics analysis of cartilage response to mechanical injury and cytokine treatment.Matrix Biol. 2017 Nov;63:11-22. doi: 10.1016/j.matbio.2016.12.004. Epub 2016 Dec 15. Matrix Biol. 2017. PMID: 27988350 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical